371 related articles for article (PubMed ID: 32726977)
1. Targeting Epigenetic Modifications in Uveal Melanoma.
Chokhachi Baradaran P; Kozovska Z; Furdova A; Smolkova B
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726977
[TBL] [Abstract][Full Text] [Related]
2. Role of Epigenetics in Uveal Melanoma.
Li Y; Jia R; Ge S
Int J Biol Sci; 2017; 13(4):426-433. PubMed ID: 28529451
[TBL] [Abstract][Full Text] [Related]
3. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
[TBL] [Abstract][Full Text] [Related]
4. EPIGENETIC CHANGES IN MALIGNANT UVEAL MELANOMA AND POSSIBILITIES OF THEIR THERAPEUTIC TARGETING.
Smolková B; Demková L
Cesk Slov Oftalmol; 2020; 76(2):55-60. PubMed ID: 33126799
[TBL] [Abstract][Full Text] [Related]
5. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2017 May; 25(5):1209-1221. PubMed ID: 28330694
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases.
Smit KN; Boers R; Vaarwater J; Boers J; Brands T; Mensink H; Verdijk RM; van IJcken WFJ; Gribnau J; de Klein A; Kilic E
Sci Rep; 2022 Jan; 12(1):42. PubMed ID: 34997020
[TBL] [Abstract][Full Text] [Related]
7. Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.
Herwig-Carl MC; Sharma A; Höller T; Holz FG; Schlitter AM; Loeffler KU
Exp Eye Res; 2019 May; 182():175-181. PubMed ID: 30954503
[TBL] [Abstract][Full Text] [Related]
8. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
11. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma: Towards a molecular understanding.
Smit KN; Jager MJ; de Klein A; Kiliҫ E
Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
[TBL] [Abstract][Full Text] [Related]
13. Advances of epigenetic editing.
Gjaltema RAF; Rots MG
Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
15. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
16. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.
Chai P; Jia R; Li Y; Zhou C; Gu X; Yang L; Shi H; Tian H; Lin H; Yu J; Zhuang A; Ge S; Jia R; Fan X
Prog Retin Eye Res; 2022 Jul; 89():101030. PubMed ID: 34861419
[TBL] [Abstract][Full Text] [Related]
17. Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Regulations for Neuropsychiatric Disorders.
Singh DD; Verma R; Parimoo P; Sahu A; Kumar V; Upadhyay E; Yadav DK
Curr Top Med Chem; 2021; 21(10):878-894. PubMed ID: 33739246
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis.
Furuya K; Ikura M; Ikura T
J Biochem; 2019 Apr; 165(4):297-299. PubMed ID: 30605533
[TBL] [Abstract][Full Text] [Related]
20.
Horvathova Kajabova V; Soltysova A; Demkova L; Plesnikova P; Lyskova D; Furdova A; Babal P; Smolkova B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
